process of radionuclide labeling of murine or human, monoclonal or polyclonal anti-tumor necrosis factor associated with diseases whose pathophysiology involves tumor necrosis factor; reagent for diagnosis 'in vivo' and / or 'in vitro' based on murine or human antibodies, monoclonal or polyclonal anti-tumor necrosis factor associated with radionuclides; diagnostic methods 'in vitro' and / or 'in vivo' of diseases whose physiotopagenia involves tumor necrosis factor using the reagent thus obtained and kit for diagnosing diseases whose pathophysiology involves tumor necrosis factor based on said reagent

摘要

process of radionuclide labeling of murine or human, monoclonal or polyclonal anti-tumor necrosis factor associated with diseases whose pathophysiology involves tumor necrosis factor; reagent for diagnosis "in vivo" and / or "in vitro" based on murine or human antibodies, monoclonal or polyclonal anti-tumor necrosis factor associated with radionuclides; diagnostic methods "in vitro" and / or "in vivo" of diseases whose pathophysiology involves tumor necrosis factor using the reagent thus obtained and kit for diagnosing diseases whose pathophysiology involves tumor necrosis factor based on said reagent. the present invention relates to a radionuclide staining process for murine or human, monoclonal or polyclonal anti-tumor necrosis factor antibodies, as well as for the diagnostic reagent "in vivo" or "in vitro" based on anti-tumor antibodies tumor necrosis factor, murine or human, monoclonal or polyclonal marked with radionuclides, its use for diagnosis, the 'in vitro' and 'in vivo' diagnosis method of diseases whose pathophysiology involves the tumor necrosis factor and the diagnostic kit immunological diseases using said reagent.